HPRA Report on Antimicrobial Resistance

Download: hpra-report-on-antimicrobial-resistance.pdf 284 KB

This report has been prepared by the HPRA at the request of its Board. The report references existing European and global reports on antimicrobial resistance (AMR) in bacteria and considers their implications for the HPRA in relation to its role as the national regulator of human and veterinary medicines.

AMR is a complex multifactorial phenomenon that impacts on human / animal health and the environment. The HPRA is one of a range agencies that is actively involved in addressing this issue both at a national and international level.

In 2014, a National Interdepartmental AMR Consultative Committee was established between the Department of Health and the Department of Agriculture, Food and the Marine. The HPRA is a member of this committee which is focused on ensuring a coordinated national approach to dealing with the issue of AMR.

In addition, the HPRA works in collaboration with the European Medicines Agency (EMA) as well as other European and global partners and is contributing to a number of specific initiatives aimed at limiting the development of resistance.

« Back